BioCentury | Jul 19, 2019
Product Development

Why GammaDelta would do its Takeda build-to-buy all over again

...competing γδ T cell therapy has already entered the clinic: TC Biopharm Ltd.’s allogeneic, unmodified blood-derived TCB002. TC Biopharm...
...Tokyo, Japan Scotia Biologics Ltd., Aberdeen, U.K. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), Tokyo, Japan TC Biopharm Ltd....
BioCentury | Oct 19, 2018
Tools & Techniques

Allogeneic CARs on the horizon

...Ltd. CMD-502 CAR-NKT cells with MHC I and II peptides down-regulated by shRNA shRNA Preclinical TC Biopharm Ltd....
BioCentury | Aug 10, 2018
Company News

Regeneron, bluebird ink multitarget deal for cancer

...partnered with at least five other companies in oncology R&D deals: γδ T cell company TC BioPharm Ltd....
...NASDAQ:GILD) and Five Prime Therapeutics Inc. (NASDAQ:FPRX). Three of the deals -- those with Celgene, TC BioPharm...
...bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Cancer Allison Johnson Adicet Bio Inc. bluebird bio Inc. Medigene AG Regeneron Pharmaceuticals Inc. TC Biopharm Ltd. Celgene...
BioCentury | Aug 6, 2018
Company News

Regeneron, bluebird in multitarget cell therapy deal

...partnered with at least five other companies in oncology R&D deals: γδ T cell company TC BioPharm Ltd....
...NASDAQ:GILD) and Five Prime Therapeutics Inc. (NASDAQ:FPRX). Three of the deals -- those with Celgene, TC BioPharm...
...$632.5 million follow-on. Regeneron dipped $4.83 to $390.05. Allison Johnson Adicet Bio Inc. bluebird bio Inc. Medigene AG Regeneron Pharmaceuticals Inc. TC Biopharm Ltd. Celgene...
BioCentury | Jul 20, 2018
Company News

Kite looks to Gadeta for gamma delta T cell tech

...also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); TC BioPharm Ltd....
BioCentury | Jul 19, 2018
Company News

Kite, Gadeta in gamma delta T cell deal

...also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); TC BioPharm Ltd....
BioCentury | May 25, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); and TC BioPharm Ltd....
BioCentury | May 23, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); and TC BioPharm Ltd....
BioCentury | May 11, 2018
Company News

TC BioPharm, Scotia Biologics in immuno-oncology deal

...deal. TC BioPharm will use its ImmuniCAR platform to develop the antibodies into CAR T-based immunotherapies. TC BioPharm's...
...and is eligible for milestones and royalties. Moussavi declined to disclose financial terms. In December, TC BioPharm...
...Dec. 8, 2017) . Scotia Biologics, Aberdeen, U.K. TC BioPharm Ltd., Edinburg, U.K. Business: Cancer Sandi Wong Scotia Biologics Ltd. TC Biopharm Ltd....
BioCentury | May 8, 2018
Company News

TC Biopharm, Scotia Biologics in immuno-oncology deal

...deal. TC BioPharm will use its ImmuniCAR platform to develop the antibodies into CAR T-based immunotherapies. TC BioPharm's...
...and is eligible for milestones and royalties. Moussavi declined to disclose financial terms. In December, TC BioPharm...
...hematologic malignancies and solid tumors using ImmuniCAR technology (see BioCentury Extra, Dec. 7, 2017) . Sandi Wong TC Biopharm Ltd. Epidermal...
Items per page:
1 - 10 of 16
BioCentury | Jul 19, 2019
Product Development

Why GammaDelta would do its Takeda build-to-buy all over again

...competing γδ T cell therapy has already entered the clinic: TC Biopharm Ltd.’s allogeneic, unmodified blood-derived TCB002. TC Biopharm...
...Tokyo, Japan Scotia Biologics Ltd., Aberdeen, U.K. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), Tokyo, Japan TC Biopharm Ltd....
BioCentury | Oct 19, 2018
Tools & Techniques

Allogeneic CARs on the horizon

...Ltd. CMD-502 CAR-NKT cells with MHC I and II peptides down-regulated by shRNA shRNA Preclinical TC Biopharm Ltd....
BioCentury | Aug 10, 2018
Company News

Regeneron, bluebird ink multitarget deal for cancer

...partnered with at least five other companies in oncology R&D deals: γδ T cell company TC BioPharm Ltd....
...NASDAQ:GILD) and Five Prime Therapeutics Inc. (NASDAQ:FPRX). Three of the deals -- those with Celgene, TC BioPharm...
...bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Cancer Allison Johnson Adicet Bio Inc. bluebird bio Inc. Medigene AG Regeneron Pharmaceuticals Inc. TC Biopharm Ltd. Celgene...
BioCentury | Aug 6, 2018
Company News

Regeneron, bluebird in multitarget cell therapy deal

...partnered with at least five other companies in oncology R&D deals: γδ T cell company TC BioPharm Ltd....
...NASDAQ:GILD) and Five Prime Therapeutics Inc. (NASDAQ:FPRX). Three of the deals -- those with Celgene, TC BioPharm...
...$632.5 million follow-on. Regeneron dipped $4.83 to $390.05. Allison Johnson Adicet Bio Inc. bluebird bio Inc. Medigene AG Regeneron Pharmaceuticals Inc. TC Biopharm Ltd. Celgene...
BioCentury | Jul 20, 2018
Company News

Kite looks to Gadeta for gamma delta T cell tech

...also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); TC BioPharm Ltd....
BioCentury | Jul 19, 2018
Company News

Kite, Gadeta in gamma delta T cell deal

...also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); TC BioPharm Ltd....
BioCentury | May 25, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); and TC BioPharm Ltd....
BioCentury | May 23, 2018
Financial News

Lava raises €16M for gamma delta T cell platform

...known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); and TC BioPharm Ltd....
BioCentury | May 11, 2018
Company News

TC BioPharm, Scotia Biologics in immuno-oncology deal

...deal. TC BioPharm will use its ImmuniCAR platform to develop the antibodies into CAR T-based immunotherapies. TC BioPharm's...
...and is eligible for milestones and royalties. Moussavi declined to disclose financial terms. In December, TC BioPharm...
...Dec. 8, 2017) . Scotia Biologics, Aberdeen, U.K. TC BioPharm Ltd., Edinburg, U.K. Business: Cancer Sandi Wong Scotia Biologics Ltd. TC Biopharm Ltd....
BioCentury | May 8, 2018
Company News

TC Biopharm, Scotia Biologics in immuno-oncology deal

...deal. TC BioPharm will use its ImmuniCAR platform to develop the antibodies into CAR T-based immunotherapies. TC BioPharm's...
...and is eligible for milestones and royalties. Moussavi declined to disclose financial terms. In December, TC BioPharm...
...hematologic malignancies and solid tumors using ImmuniCAR technology (see BioCentury Extra, Dec. 7, 2017) . Sandi Wong TC Biopharm Ltd. Epidermal...
Items per page:
1 - 10 of 16